73 related articles for article (PubMed ID: 23999419)
1. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa.
Mitchell SM; Sekikubo M; Biryabarema C; Byamugisha JJ; Steinberg M; Jeronimo J; Money DM; Christilaw J; Ogilvie GS
Am J Obstet Gynecol; 2014 Jan; 210(1):81.e1-7. PubMed ID: 23999419
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community.
Sangwa-Lugoma G; Ramanakumar AV; Mahmud S; Liaras J; Kayembe PK; Tozin RR; Lorincz A; Franco EL
Sex Transm Dis; 2011 Apr; 38(4):308-15. PubMed ID: 21150817
[TBL] [Abstract][Full Text] [Related]
3. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.
Sellors JW; Mahony JB; Kaczorowski J; Lytwyn A; Bangura H; Chong S; Lorincz A; Dalby DM; Janjusevic V; Keller JL
CMAJ; 2000 Sep; 163(5):503-8. PubMed ID: 11006760
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South Africa.
Mahomed K; Evans D; Sauls C; Richter K; Smith J; Firnhaber C
Pan Afr Med J; 2014; 17():189. PubMed ID: 25396015
[TBL] [Abstract][Full Text] [Related]
7. [Genital human papillomavirus (HPV) infection in women in the province of Asti (Italy)].
Salfa MC; Bocci C; Lillo F; Regine V; Brunini S; Camoni L; Barbero M; Suligoi B
Ig Sanita Pubbl; 2011; 67(4):425-37. PubMed ID: 22033201
[TBL] [Abstract][Full Text] [Related]
8. Self-collection for high-risk HPV detection in Brazilian women using the careHPV™ test.
Lorenzi AT; Fregnani JH; Possati-Resende JC; Neto CS; Villa LL; Longatto-Filho A
Gynecol Oncol; 2013 Oct; 131(1):131-4. PubMed ID: 23880151
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction.
Gravitt PE; Lacey JV; Brinton LA; Barnes WA; Kornegay JR; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Zaino R; Hildesheim A
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):95-100. PubMed ID: 11219778
[TBL] [Abstract][Full Text] [Related]
10. HPV self-sampling as primary screening test in sub-Saharan Africa: implication for a triaging strategy.
Untiet S; Vassilakos P; McCarey C; Tebeu PM; Kengne-Fosso G; Menoud PA; Boulvain M; Navarria I; Petignat P
Int J Cancer; 2014 Oct; 135(8):1911-7. PubMed ID: 24615324
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
13. [Study of the association between human papillomavirus infection and cervical cancer in Xianguan county, Shanxi province].
Zhao F; Li N; Ma J
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Oct; 22(5):375-8. PubMed ID: 11769697
[TBL] [Abstract][Full Text] [Related]
14. Self-collection based HPV testing for cervical cancer screening among women living with HIV in Uganda: a descriptive analysis of knowledge, intentions to screen and factors associated with HPV positivity.
Mitchell SM; Pedersen HN; Eng Stime E; Sekikubo M; Moses E; Mwesigwa D; Biryabarema C; Christilaw J; Byamugisha JK; Money DM; Ogilvie GS
BMC Womens Health; 2017 Jan; 17(1):4. PubMed ID: 28086933
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical performance of high-risk human papillomavirus testing for primary screening: a retrospective review of the Southern California Permanente Medical Group experience.
Lonky NM; Mahdavi A; Wolde-Tsadik G; Bajamundi K; Felix JC
J Low Genit Tract Dis; 2010 Jul; 14(3):200-5. PubMed ID: 20592555
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study.
Thomas JO; Herrero R; Omigbodun AA; Ojemakinde K; Ajayi IO; Fawole A; Oladepo O; Smith JS; Arslan A; Muñoz N; Snijders PJ; Meijer CJ; Franceschi S
Br J Cancer; 2004 Feb; 90(3):638-45. PubMed ID: 14760378
[TBL] [Abstract][Full Text] [Related]
17. [Study on subtype of human papillomavirus infection among aged 25 - 54 reproductive women in Beijing from 2006 to 2008].
Zhao R; Zhang WY; Zhang SW; Wu MH; Wang JD; Xie Z; Feng J; Pan J; Wang JH; Liu XZ
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):184-7. PubMed ID: 21575451
[TBL] [Abstract][Full Text] [Related]
18. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
Laskow B; Figueroa R; Alfaro KM; Scarinci IC; Conlisk E; Maza M; Chang JC; Cremer M
Int J Gynaecol Obstet; 2017 Aug; 138(2):194-200. PubMed ID: 28589548
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
